Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer

BACKGROUND: Published data suggests that docetaxel combined with 5-fluorouracil (5-FU) may have synergistic activity in treating advanced gastric cancer. We performed a phase I study of docetaxel and 5-FU to determine the maximum tolerated dose (MTD), the recommended dose for phase II studies, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Se Hoon, Bang, Soo-Mee, Cho, Eun Kyung, Shin, Dong Bok, Lee, Jae Hoon, Lee, Woon KI, Chung, Min
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1183196/
https://www.ncbi.nlm.nih.gov/pubmed/16042786
http://dx.doi.org/10.1186/1471-2407-5-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1183196/
https://www.ncbi.nlm.nih.gov/pubmed/16042786
http://dx.doi.org/10.1186/1471-2407-5-87

Ejemplares similares